Evidence map›Paper›PMID 30245648›Full record

ArticleFrontiers in psychology2018

Psychedelics, Meditation, and Self-Consciousness.

Raphaël Millière, Robin L Carhart-Harris, Leor Roseman, Fynn-Mathis Trautwein, Aviva Berkovich-Ohana

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 394 citations in OpenAlex.

  1. Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  7. Trial
  8. The entropic brain today.Brain : a journal of neurology · 2026
    Review
  9. Article
  10. A contemporary exploration of motivations and practices of psychedelic use among emerging adult cannabis users in the United States: A qualitative analysis.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2026
    Article
  11. Speech markers of psychological change following a psychedelic 5-MeO-DMT retreat.Journal of psychopharmacology (Oxford, England) · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Raphaël MillièreFaculty of Philosophy, University of Oxford, Oxford, United Kingdom.
Robin L Carhart-HarrisPsychedelic Research Group, Psychopharmacology Unit, Department of Medicine, Centre for Psychiatry, Imperial College London, London, United Kingdom.
Leor RosemanPsychedelic Research Group, Psychopharmacology Unit, Department of Medicine, Centre for Psychiatry, Imperial College London, London, United Kingdom.
Fynn-Mathis TrautweinDepartment of Social Neuroscience, Max-Planck-Institut für Kognitions- und Neurowissenschaften, Leipzig, Germany.
Aviva Berkovich-OhanaFaculty of Education, Edmond Safra Brain Research Center, University of Haifa, Haifa, Israel.
Imperial College London · GBMax Planck Institute for Human Cognitive and Brain Sciences · DEUniversity of Haifa · ILUniversity of Oxford · GB

Funding

Conference on Clinical Research for Rare Diseases (CCRRD)R13TR001587 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MERKEL, PETER A · 2016 to 2020
$209k
NCATS NIH HHS R13 TR001587
6 · The paper itself

Abstract

In recent years, the scientific study of meditation and psychedelic drugs has seen remarkable developments. The increased focus on meditation in cognitive neuroscience has led to a cross-cultural classification of standard meditation styles validated by functional and structural neuroanatomical data. Meanwhile, the renaissance of psychedelic research has shed light on the neurophysiology of altered states of consciousness induced by classical psychedelics, such as psilocybin and LSD, whose effects are mainly mediated by agonism of serotonin receptors. Few attempts have been made at bridging these two domains of inquiry, despite intriguing evidence of overlap between the phenomenology and neurophysiology of meditation practice and psychedelic states. In particular, many contemplative traditions explicitly aim at dissolving the sense of self by eliciting altered states of consciousness through meditation, while classical psychedelics are known to produce significant disruptions of self-consciousness, a phenomenon known as drug-induced ego dissolution. In this article, we discuss available evidence regarding convergences and differences between phenomenological and neurophysiological data on meditation practice and psychedelic drug-induced states, with a particular emphasis on alterations of self-experience. While both meditation and psychedelics may disrupt self-consciousness and underlying neural processes, we emphasize that neither meditation nor psychedelic states can be conceived as simple, uniform categories. Moreover, we suggest that there are important phenomenological differences even between conscious states described as experiences of self-loss. As a result, we propose that self-consciousness may be best construed as a multidimensional construct, and that "self-loss," far from being an unequivocal phenomenon, can take several forms. Indeed, various aspects of self-consciousness, including narrative aspects linked to autobiographical memory, self-related thoughts and mental time travel, and embodied aspects rooted in multisensory processes, may be differently affected by psychedelics and meditation practices. Finally, we consider long-term outcomes of experiences of self-loss induced by meditation and psychedelics on individual traits and prosocial behavior. We call for caution regarding the problematic conflation of temporary states of self-loss with "selflessness" as a behavioral or social trait, although there is preliminary evidence that correlations between short-term experiences of self-loss and long-term trait alterations may exist.

Indexed as

autobiographical memorybodily self-consciousnessconsciousnessmeditationmental time travelmind wanderingpsychedelicsself-consciousness

Identifiers

PMID30245648
PMCPMC6137697
OpenAlexW2892061340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.